Devon Park Bioventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Devon Park Bioventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 16, 2014	Proteon Therapeutics	$45.0M Series D	Tim Haines	Bessemer Venture Partners, Deerfield Management, Intersouth Partners, MPM Capital, Dmitry Kobyzev, Ph.D., Prism VentureWorks, Skyline Ventures, TVM Capital, Vectis Healthcare and Life Sciences Fund
Mar 1, 2014	ZS Pharma	$55.0M Series D	Novo Holdings	RiverVest, 3x5 Special Opportunity Fund, Adage Capital Management, Alta Partners, RA Capital Management, RiverVest Venture Partners, Salem Partners, Sofinnova Ventures
Aug 22, 2013	MicuRx Pharmaceuticals	$25.0M Series B	Davis Yang	Morningside
May 23, 2013	Cardeas Pharma	$34.0M Series B	Aaron Davidson	Avalon Ventures, Delphi Ventures, Novo Holdings, WRF Capital
Oct 28, 2012	ZS Pharma	$46.0M Other Equity	Robert Alexander	3x5 Special Opportunity Fund, John McKearn, Salem Partners
Feb 22, 2012	Vascular Magnetics	$7.0M Series A	Christopher Moller	—
Jul 1, 2010	Cara Therapeutics	$15.0M Series D	Martin Vogelbaum	Connecticut Innovations, Digitalis Ventures, Alta Partners, Ascent Biomedical Ventures, Healthcare Private Equity, Mitsubishi Corporation, MVM Partners